Compare TWST & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | STEW |
|---|---|---|
| Founded | 2013 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2018 | N/A |
| Metric | TWST | STEW |
|---|---|---|
| Price | $46.04 | $18.09 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $47.89 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 84.5K |
| Earning Date | 02-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $391,557,000.00 | N/A |
| Revenue This Year | $16.77 | N/A |
| Revenue Next Year | $15.06 | N/A |
| P/E Ratio | ★ N/A | $10.34 |
| Revenue Growth | ★ 18.59 | N/A |
| 52 Week Low | $23.30 | $11.97 |
| 52 Week High | $54.74 | $14.94 |
| Indicator | TWST | STEW |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 52.26 |
| Support Level | $39.66 | $17.90 |
| Resistance Level | $43.34 | $17.80 |
| Average True Range (ATR) | 2.50 | 0.17 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 77.41 | 64.50 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.